胸主动脉腔内修复术后腹腔干覆盖的早期与晚期结果:一项Meta分析
该Meta分析纳入13项观察性研究,共2653例胸主动脉腔内修复(TEVAR),其中178例覆盖腹腔干(7%)。早期脊髓缺血8%,任何内漏12%,IB型内漏5%,TEVAR相关再手术8%,死亡率9%;随访12至42个月,晚期内脏并发症15%,任何内漏20%,IB型内漏8%,再干预8%,死亡率17%。作者认为腹腔干覆盖在急症中可作为「补救」措施,择期需谨慎。
要点
- TEVAR中腹腔干覆盖率7%,早期脊髓缺血8%,任何内漏12%,IB型内漏5%。
- 早期TEVAR相关再手术8%,其中78%因远端密封失败;死亡率9%。
- 晚期内脏并发症15%,任何内漏20%,IB型内漏8%,再干预8%,死亡率17%。
核心结论
- 腹腔干覆盖在降胸主动脉病变中应视为「补救」措施,尤其在紧急/急诊情况下,但在择期病例中需谨慎。
- 即使短暂内脏缺血常见,危及生命的并发症罕见;早期和晚期死亡率与标准TEVAR相似,但IB型内漏和再干预风险可能是个问题。
研究设计与样本
- 纳入前瞻性和回顾性观察性原创文章,聚焦择期/紧急TEVAR治疗降胸主动脉病变时的腹腔干覆盖。
- 检索PubMed/MEDLINE、Embase和Cochrane Central Register of Controlled Trials数据库,纳入2007年1月至2020年12月发表的文献,遵循PRISMA指南。
- 共提取5618篇文章分析,最终13项研究纳入合成;2653例TEVAR中178例腹腔干被覆盖(7%)。
主要发现
- 早期脊髓缺血8%(95% CI,5-14%,I² 0%);任何内漏12%(95% CI,6-21%,I² 17%),IB型内漏5%(95% CI,2-11%,I² 0%)。
- 早期TEVAR相关再手术8%(95% CI,4-14%,I² 0%),其中多数(14/18,78%)因远端密封失败;死亡率9%(95% CI,5-14%,I² 0%)。
- 178例中168例(94%)可随访,随访时间12至42个月;晚期内脏并发症15%(95% CI,10-23%,I² 45%),任何内漏20%(95% CI,13-29%,I² 8%),IB型内漏8%(95% CI,4-15%,I² 0%)。
- 晚期TEVAR相关再干预8%(95% CI,4-14%,I² 0%);死亡率17%(95% CI,12-25%,I² 4%)。
临床怎么用
- 作者认为腹腔干覆盖在降胸主动脉病变中应视为「补救」措施,尤其在紧急/急诊情况下,但在择期病例中需谨慎。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIM: Clinical outcomes of celiac artery (CA) coverage during aortic procedures are often contradicting and the fate of this additional maneuver is still unclear. This study summarizes the results of available literature and aims to clarify the impact of CA coverage during thoracic endovascular aneurysm repair (TEVAR) in patients with inadequate distal sealing zone. METHODS: Prospective and retrospective, observational original articles focused on CA coverage during elective/urgent TEVAR for descending thoracic aortic pathology (DTAP) were included. PubMed/MEDLINE, Embase, and Cochrane Central Register of Controlled Trials database were examined to identify articles published from January 2007 to December 2020, according to PRISMA guidelines. Early and late visceral (any sign or symptom reported) and neurological (both transient and permanent) complications were considered as primary outcomes. Onset of any endoleak, type IB endoleak, need of reintervention, and TEVAR-related mortality were considered as secondary outcomes. RESULTS: A total of 5618 articles were extracted for analysis and 13 studies were finally included in the synthesis. A total of 178 CAs were covered during 2653 TEVAR (7%). Spinal cord ischemia was 8% (95% CI, 5-14%, I2 0%) Any endoleak and type IB endoleak was observed in 12% (95% CI, 6-21%, I2 17%) and 5% (95% CI, 2-11%, I2 0%), respectively. Thoracic endovascular aneurysm repair-related reoperation was necessary in 8% (95% CI, 4-14%, I2 0%), the majority of which (14/18, 78%) performed for distal sealing failure; mortality rate was 9% (95% CI, 5-14%, I2 0%). Out of 178 patients, 168 (94%) were available for follow-up, ranged 12 to 42 months. Visceral complications, any endoleak, and type IB endoleak were identified in 15% (95% CI, 10-23%, I2 45%), 20% (95% CI, 13-29%, I2 8%), and 8% (95% CI, 4-15%, I2 0%), respectively. Thoracic endovascular aneurysm repair-related reintervention was required in 8% (95% CI, 4-14%, I2 0%). Mortality rate was 17% (95% CI, 12-25%, I2 4%). CONCLUSIONS: Celiac artery coverage in DTAP should be regarded as a "bailout" procedure especially in urgent/emergent settings but requires caution in elective cases. Even if transient visceral ischemia is frequent, life-threatening complications are rare. Early and late mortality rates are similar to standard TEVAR although the risk of type IB endoleak and reintervention may be an issue.
引用
- Mezzetto L, Mastrorilli D, Bravo G, et al. Celiac Artery Coverage After Thoracic Endovascular Aortic Procedure: A Meta-Analysis of Early and Late Results. J Endovasc Ther. 2022. PMID: 35466769. doi:10.1177/15266028221090443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。